Explore the complex link between diabetes and cancer, shared risk factors, and emerging research to enhance prevention and treatment strategies.
Read More »New Information in Diabetes Research: What Clinicians Need to Know
Discover groundbreaking diabetes research breakthroughs offering new hope for treatment and management of this chronic condition.
Read More »How is Empagliflozin Used In Diabetes Care?
Discover how empagliflozin, an SGLT2 inhibitor, enhances diabetes care by managing blood sugar, promoting weight loss, and reducing cardiovascular risks.
Read More »New Research: 1 in 4 US Adults with Diabetes Tried GLP-1 Drugs
New research reveals 1 in 4 U.S. adults with diabetes have tried GLP-1 drugs, highlighting a shift in diabetes management with these innovative treatments.
Read More »Why Diabetes Tech Is On The Rise?
Discover how diabetes tech is transforming care with innovative tools for better management and improved patient outcomes globally.
Read More »Why Some Patients Think They Have Diabetes In Control
Explore why some patients mistakenly believe they have diabetes in control, highlighting the importance of continuous monitoring and patient education.
Read More »What is Sitagliptin?
Discover the role of Sitagliptin, a DPP-4 inhibitor, in managing type 2 diabetes by enhancing the body's natural insulin response.
Read More »Diabetes Basics: What is Dulaglutide?
Explore Dulaglutide, a GLP-1 receptor agonist, and its role in managing type 2 diabetes by improving blood sugar control and overall health.
Read More »New Study: Are Diabetes and French Fries Linked?
A new study examines the link between diabetes and French fries, highlighting potential health risks and dietary recommendations.
Read More »What are the Causes of Prediabetes?
Discover the causes of prediabetes, from genetic predispositions to lifestyle choices, and learn how to reduce your risk of developing this condition.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.